Overlaping Syndromes: Kawasaki-Like Disease in Pediatric Multisystem Inflammatory Syndrome vs Atypical Kawasaki Disease. British or American? One Case, Many Possibilities

1 McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Pahl E. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation, 2017;135(17), e927–e999. doi:10.1161/cir.0000000000000484 McCrindleBW RowleyAH NewburgerJW BurnsJC BolgerAF GewitzM PahlE Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association Circulation 2017 135 17 e927 e999 10.1161/cir.0000000000000484 Open DOISearch in Google Scholar

2 Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatrica, 83(10), 1057–1060. doi:10.1111/j.1651-2227.1994.tb12985.x FukushigeJ TakahashiN UedaY UedaK Incidence and clinical features of incomplete Kawasaki disease Acta Paediatrica 83 10 1057 1060 10.1111/j.1651-2227.1994.tb12985.x Open DOISearch in Google Scholar

3 Morishita KA, Goldman RD. Kawasaki disease recognition and treatment. Can Fam Physician. 2020;66(8): 577–579. MorishitaKA GoldmanRD Kawasaki disease recognition and treatment Can Fam Physician 2020 66 8 577 579 Search in Google Scholar

4 Pilania RK, Bhattarai D, Singh S. Controversies in diagnosis and management of Kawasaki disease. World Journal of Clinical Pediatrics, 2018;7(1), 27–35. doi:10.5409/wjcp.v7.i1.27 PilaniaRK BhattaraiD SinghS Controversies in diagnosis and management of Kawasaki disease World Journal of Clinical Pediatrics 2018 7 1 27 35 10.5409/wjcp.v7.i1.27 Open DOISearch in Google Scholar

5 Marchesi A, Rigante D, Cimaz R, Ravelli A, Tarissi de Jacobis I, Rimini A, et al. Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease. Italian Journal of Pediatrics. 2021;47:16. https://doi.org/10.1186/s13052-021-00962-4 MarchesiA RiganteD CimazR RavelliA Tarissi de JacobisI RiminiA Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease Italian Journal of Pediatrics 2021 47 16 https://doi.org/10.1186/s13052-021-00962-4 10.1186/s13052-021-00962-4 Search in Google Scholar

6 Vignesh P, Bhattad S, Singhal M, Singh S. A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease? Rheumatology International, 2016;36(8), 1191–1193. doi:10.1007/s00296-016-3490-7 VigneshP BhattadS SinghalM SinghS A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease? Rheumatology International 2016 36 8 1191 1193 10.1007/s00296-016-3490-7 Open DOISearch in Google Scholar

7 Royal College of Paediatrics and Child Health. Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19. Accessed May 22, 2020. https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19 Royal College of Paediatrics and Child Health Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19 Accessed May 22, 2020. https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19 Search in Google Scholar

8 Whittaker E, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 [published online June 8, 2020]. JAMA. https://doi.org/10.1001/jama.2020.10369 WhittakerE Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 [published online June 8, 2020] JAMA https://doi.org/10.1001/jama.2020.10369 10.1001/jama.2020.10369 Search in Google Scholar

9 Elias MD, McCrindle BW, Larios G, Choueiter NF, Dahdah N, Harahsheh AS, et al. Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease Registry. CJC Open [Internet]. 2020 Nov 1;2(6):632–40. EliasMD McCrindleBW LariosG ChoueiterNF DahdahN HarahshehAS Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease Registry CJC Open [Internet] 2020 Nov 1 2 6 632 40 10.1016/j.cjco.2020.09.004 Search in Google Scholar

10 Centers for Disease Control and Prevention. Emergency preparedness and response: health alert network. Published May 14, 2020. Centers for Disease Control and Prevention Emergency preparedness and response: health alert network Published May 14, 2020. Search in Google Scholar

11 WHO. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. 15 May 2020. https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. WHO Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 15 May 2020 https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Search in Google Scholar

12 Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D’Anitga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020. Advance online publication, doi: 10.1016/S0140-6736(20)31129-6 VerdoniL MazzaA GervasoniA MartelliL RuggeriM CiuffredaM BonanomiE D’AnitgaL An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study Lancet 2020 Advance online publication, 10.1016/S0140-6736(20)31129-6 Open DOISearch in Google Scholar

13 Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, Klein JD, Bhutta ZA. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20(11):e276–e288. doi: 10.1016/S1473-3099(20)30651-4. JiangL TangK LevinM IrfanO MorrisSK WilsonK KleinJD BhuttaZA COVID-19 and multisystem inflammatory syndrome in children and adolescents Lancet Infect Dis 2020 20 11 e276 e288 10.1016/S1473-3099(20)30651-4 Open DOISearch in Google Scholar

14 Kabeerdoss J, Pilania RK, Karkhele R, Kumar TS, Danda D, Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int. 2020 Nov 21:1–14. doi: 10.1007/s00296-020-04749-4 KabeerdossJ PilaniaRK KarkheleR KumarTS DandaD SinghS Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management Rheumatol Int 2020 Nov 21 1 14 10.1007/s00296-020-04749-4 768008033219837 Open DOISearch in Google Scholar

15 Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol. 1990;56:29–36. MatsubaraT FurukawaS YabutaK Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions Clin Immunol Immunopathol 1990 56 29 36 10.1016/0090-1229(90)90166-N Search in Google Scholar

16 Shafferman A, Birmingham JD, Cron RQ. High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report. Pediatr Rheumatol Online J. 2014;12:26. doi: 10.1186/1546-0096-12-26. ShaffermanA BirminghamJD CronRQ High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report Pediatr Rheumatol Online J 2014 12 26 10.1186/1546-0096-12-26 410397625045337 Open DOISearch in Google Scholar

17 Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis. Annals of the Rheumatic Diseases, 2016;75(3), 481–489. doi:10.1136/annrheumdis-2015-208982 RavelliA MinoiaF DavìS HorneA BovisF PistorioA 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis Annals of the Rheumatic Diseases 2016 75 3 481 489 10.1136/annrheumdis-2015-208982 26865703 Open DOISearch in Google Scholar

18 Cohen S, Tacke CE, Straver B, Meijer N, Kuipers IM, Kuijpers TW. A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation. Annals of the Rheumatic Diseases, 2012;71(12), 2059–2061. doi:10.1136/annrheumdis-2012-201658 CohenS TackeCE StraverB MeijerN KuipersIM KuijpersTW A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation Annals of the Rheumatic Diseases 2012 71 12 2059 2061 10.1136/annrheumdis-2012-201658 22689319 Open DOISearch in Google Scholar

19 Printz BF, Sleeper LA, Newburger JW, Minich LL, Bradley T, Cohen MS, Frank D, Li JS, Margossian R, Shirali G, Takahashi M, Colan SD; Pediatric Heart Network Investigators. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol. 2011;57:86–92. doi: 10.1016/j.jacc.2010.08.619. PrintzBF SleeperLA NewburgerJW MinichLL BradleyT CohenMS FrankD LiJS MargossianR ShiraliG TakahashiM ColanSD Pediatric Heart Network Investigators Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease J Am Coll Cardiol 2011 57 86 92 10.1016/j.jacc.2010.08.619 357706821185506 Open DOISearch in Google Scholar

20 Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP. The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med. 1986;315:341–347. doi:10.1056/NEJM198608073150601. NewburgerJW TakahashiM BurnsJC BeiserAS ChungKJ DuffyCE GlodeMP MasonWH ReddyV SandersSP The treatment of Kawasaki syndrome with intravenous gammaglobulin N Engl J Med 1986 315 341 347 10.1056/NEJM198608073150601 2426590 Open DOISearch in Google Scholar

21 Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633–1639. doi: 10.1056/NEJM199106063242305. NewburgerJW TakahashiM BeiserAS BurnsJC BastianJ ChungKJ ColanSD DuffyCE FultonDR GlodeMP A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome N Engl J Med 1991 324 1633 1639 10.1056/NEJM199106063242305 1709446 Open DOISearch in Google Scholar

22 Kato H. Cardiovascular complications in Kawasaki disease: Coronary artery lumen and long-term consequences. Progress in Pediatric Cardiology. 2004 Dec 1;19(2 SPEC.ISS.):137–45. KatoH Cardiovascular complications in Kawasaki disease: Coronary artery lumen and long-term consequences Progress in Pediatric Cardiology 2004 Dec 1 19 2 SPEC.ISS. 137 45 10.1016/j.ppedcard.2004.08.007 Search in Google Scholar

23 Jindal AK, Pilania RK, Prithvi A, Guleria S, Singh S. Kawasaki disease: characteristics, diagnosis, and unusual presentations. Expert Review of Clinical Immunology. 2019; 3;15(10):1089–104. JindalAK PilaniaRK PrithviA GuleriaS SinghS Kawasaki disease: characteristics, diagnosis, and unusual presentations Expert Review of Clinical Immunology 2019 3 15 10 1089 104 10.1080/1744666X.2019.165972631456443 Search in Google Scholar

24 Pilania RK, Jindal AK, Bhattarai D, Naganur SH, Singh S. Cardiovascular Involvement in Kawasaki Disease Is Much More Than Mere Coronary Arteritis. Frontiers in Pediatrics. 2020;24;0:627. PilaniaRK JindalAK BhattaraiD NaganurSH SinghS Cardiovascular Involvement in Kawasaki Disease Is Much More Than Mere Coronary Arteritis Frontiers in Pediatrics 2020 24 0:627. 10.3389/fped.2020.526969754223733072669 Search in Google Scholar